Selected article for: "general population and Italy general population"

Author: Lazzerini, M.; Sforzi, I.; Trapani, S.; Biban, P.; Salvigni, D.; Mariani, I.; Villa, G.; Tibaldi, J.; Bertacca, L.; Felici, E.; Perricone, G.; Parrino, R.; Gioe', C.; Lega, S.; Conte, M.; Marchetti, F.; Magista, A.; Berlese, P.; Martelossi, S.; Vaienti, F.; Valletta, E.; Mauro, M.; Dall Amico, R.; Fasoli, S.; Gatto, A.; Chiaretti, A.; Dragovic, D.; Pascolo, P.; Pilotto, C.; Liguoro, I.; Miorin, E.; Saretta, F.; Trobia, G.; Di Stefano, A.; Orlandi, A.; Cardinale, F.; Lubrano, R.; Testa, A.; Binotti, M.; Moressa, V.; Barbi, E.; Armocida, B.
Title: Characteristics and risk factors for SARS-CoV-2 among children in Italy: a cross-sectional study in 20 pediatric centers
  • Cord-id: ns2emsrp
  • Document date: 2021_3_17
  • ID: ns2emsrp
    Snippet: Background: No study has described factors associated with COVID-19 diagnosis in children. Aim: Describe characteristics and risk factors for COVID-19 diagnosis in children tested in 20 pediatric centers across Italy. Methods: Cases aged 0-18 years tested for SARS-CoV-2 between February 23 and May 24 2020 were included. Our primary analysis focused on children tested because of COVID-19 suggestive symptoms. Results: Among 2494 children tested for SARS-CoV-2, 2148 (86.1%) had symptoms suggestive
    Document: Background: No study has described factors associated with COVID-19 diagnosis in children. Aim: Describe characteristics and risk factors for COVID-19 diagnosis in children tested in 20 pediatric centers across Italy. Methods: Cases aged 0-18 years tested for SARS-CoV-2 between February 23 and May 24 2020 were included. Our primary analysis focused on children tested because of COVID-19 suggestive symptoms. Results: Among 2494 children tested for SARS-CoV-2, 2148 (86.1%) had symptoms suggestive of COVID-19. Clinical presentation of SARS-CoV-2 included, beside fever (82.4%) and respiratory signs or symptoms (60.4%), also gastrointestinal (18.2%), neurological (18.9%), cutaneous (3.8%) and other flu-like presentations (17.8%). In multivariate analysis, factors significantly associated with SARS-CoV-2 were: exposure history (adjusted OR 39.83 95%CI 17.52-90.55 p<0.0001), cardiac disease (adjusted OR 3.10 95%CI 1.19- 5.02 p<0.0001), fever (adjusted OR 3.05 % 95% CI 1.67-5.58 p=0.0003), and anosmia/ageusia (OR 4.08 95%CI 1.69 -9.84 p=0.002). Among 190 (7.6%) children diagnosed with SARS-CoV-2, only four (2.1%) required respiratory support and two (1.1%) were admitted in ICU, while 100% recovered. Conclusion: Recommendations for SARS-CoV-2 testing in children should be updated based on the evidence of broader clinical features. Exposure history, fever, and anosmia/ageusia are strong risk factors for COVID-19 in children, while other symptoms do not seem helping discriminating in between the SARS-CoV-2 positive and the negative cases. This study confirm that COVID-19 is a mild disease in the general population of children in Italy. Further studies are needed to understand the risk, clinical spectrum and outcomes of COVID-19 in children with specific preexisting conditions.

    Search related documents:
    Co phrase search for related documents